CI Add to watchlist $303.35 1.15 (-0.38%) Last updated: Jul 15, 2026 02:21
52-Week Range
$303.35
$239.51 $303.35 $315.47

Fundamentals Overview

Cigna Corporation is near the high of its 52-week range with attractive valuation, trading relatively flat today.

Valuation attractive

P/E 12.8 PEG 0.51 P/B 1.89 P/S 0.29

Intrinsic value (DCF)

+542.9% upside vs price

Profitability

Net margin 2.3%

Risk (Beta)

0.3 — lower vol

Earnings & growth

EPS $23.80 Rev -5.5% Profit +34% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 64% confidence Risk: Lower Volatility — Beta 0.3. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +542.9% upside vs price · Analyst grade: A-

Pressures (Sell):

Sentiment weakening (2 downgrades)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$80.25B
P/E (TTM)
12.75
EPS (TTM)
$23.80
Dividend Yield
2.02%
52-Week Range
$239.51 - $315.47
Volume vs Avg
N/A
Beta
0.3

About

Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including pharmacy services, benefits administration, care management and delivery, and advanced intelligence solutions. These offerings cater to a diverse clientele, such as health plans, emplo...
Sector: Healthcare
Headquarters: US
Employees: 67,700
IPO Date: Mar 1982
Beta: 0.3 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 10, Equal Weight: 3, Hold: 1, Market Perform: 1, Outperform: 6, Overweight: 9.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $1,950.18; current price is $303.35. That’s a +542.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 12.75
DCF value (model) $1,950.18 (542.9% upside)
PEG (TTM) 0.51
P/B (TTM) 1.89
P/S (TTM) 0.29
P/FCF (TTM) 10.48
Liquidity & enterprise
Current Ratio (TTM) 0.82
Quick Ratio (TTM) 0.71
Cash Ratio (TTM) 0.13
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 2.26%
Gross margin (TTM) 9.3%
Operating margin (TTM) 3.42%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CI.

Analyst Sentiment at a Glance

A- Sentiment Weakening
Buy 10Equal Weight 3Hold 1Market Perform 1Outperform 6Overweight 9
1 upgrade, 2 downgrades
Price Target Consensus
Current $303.35
Median $340.00
Consensus $341.82
Low consensus $302.00
High consensus $400.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Bernstein maintain Outperform Outperform 2026-07-09
Mizuho maintain Outperform Outperform 2026-06-08
Barclays downgrade Overweight Equal Weight 2026-05-26
UBS maintain Buy Buy 2026-05-22
Deutsche Bank downgrade Buy Hold 2026-05-20
Morgan Stanley maintain Overweight Overweight 2026-05-20
Bernstein maintain Outperform Outperform 2026-05-05
Guggenheim maintain Buy Buy 2026-05-04
RBC Capital maintain Outperform Outperform 2026-05-01
Cantor Fitzgerald maintain Overweight Overweight 2026-05-01
Barclays maintain Overweight Overweight 2026-05-01
Wells Fargo maintain Equal Weight Equal Weight 2026-05-01
Jefferies maintain Buy Buy 2026-04-20
Bernstein upgrade Market Perform Outperform 2026-03-12
Piper Sandler maintain Overweight Overweight 2026-03-03
Truist Securities maintain Buy Buy 2026-02-17
TD Cowen maintain Buy Buy 2026-02-09
RBC Capital maintain Outperform Outperform 2026-02-06
Barclays maintain Overweight Overweight 2026-02-06
Guggenheim maintain Buy Buy 2026-02-06
Guggenheim maintain Buy Buy 2026-02-02
Barclays maintain Overweight Overweight 2026-01-05
Truist Securities maintain Buy Buy 2026-01-05
Bernstein maintain Market Perform Market Perform 2025-11-12
Wells Fargo maintain Equal Weight Equal Weight 2025-11-05
JP Morgan maintain Overweight Overweight 2025-11-04
TD Cowen maintain Buy Buy 2025-11-04
Goldman Sachs maintain Buy Buy 2025-11-04
Barclays maintain Overweight Overweight 2025-11-03
Barclays maintain Overweight Overweight 2025-09-04